CDC-RFA-TO23-2304: Preventive Health and Health Services Block Grant– 2023 CDC-RFA-TO23-2304
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of CENTERS FOR DISEASE CONTROL CSTLTS notices from 2023.
CENTERS FOR DISEASE CONTROL CSTLTS offered grants to state and local governments. It expected to make about 61 awards worth $146 million in total. Applications closed on July 1, 2023.
From the official notice on Grants.gov, last changed April 12, 2023. Checked November 7, 2026.
- Total funding$146 million
- Expected awards61
- Cost sharingRequired
- Funding typeGrant
Key dates
| Posted | April 12, 2023 |
|---|---|
| Deadline | July 1, 2023 |
| Archived by Grants.gov | July 31, 2023 |
Who can apply
This opportunity was open to state and local governments.
- State governments
This program provides all 50 states, the District of Columbia, 2 American Indian Tribes, 5 U.S. Territories, and 3 Freely Associated States as identified in the authorizing statute with funding to address their own unique public health needs and challenges with innovative and locally defined methods.
Is this a realistic fit?
- Most of the program's money (96% over five years) went to state and local governments.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
The Preventive Health and Health Services (PHHS) Block Grant Program allows recipients to address their own unique public health needs and challenges with innovative and community-driven methods. Recipients set their own goals and program objectives and implement local strategies to address Healthy People 2030 priorities.
Who has won Preventive Health and Health Services Block Grant grants before
From fiscal 2021 to 2025, Preventive Health and Health Services Block Grant (93.991) awarded $721 million across 303 grant awards, an average of $2.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| NYS Department of Health | New York | 5 | $56.1 million |
| California Department of Public Health | California | 5 | $54.1 million |
| Pennsylvania Department of Health | Pennsylvania | 5 | $39.0 million |
| Ohio Department of Health | Ohio | 5 | $36.0 million |
| Department of State Health Services | Texas | 5 | $33.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-TO23-2304 still open?
No. It closed on July 1, 2023.
Who can apply for Preventive Health and Health Services Block Grant– 2023 CDC-RFA-TO23-2304?
CENTERS FOR DISEASE CONTROL CSTLTS accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.
What is the deadline for Preventive Health and Health Services Block Grant– 2023 CDC-RFA-TO23-2304?
Closed July 1, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $146 million in total across about 61 awards.
Who has won Preventive Health and Health Services Block Grant grants before?
The largest recipients over five fiscal years were NYS Department of Health, California Department of Public Health, Pennsylvania Department of Health. The program made 303 awards worth $721 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)